Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC

Authors:

Abstract
No abstract available
Funding Information
  • Spectrum Pharmaceuticals
  • Genentech
  • Santé (32667)
  • University of Texas MD Anderson Cancer Center
  • Merck
  • Takeda Pharmaceutical Company
  • Cancer Prevention and Research Institute of Texas (RP160668)
  • Boehringer Ingelheim
  • Exelixis
  • Johnson & Johnson Innovative Medicine
  • Bayer Fund
  • North Carolina GlaxoSmithKline Foundation
  • AstraZeneca
  • Bill and Katie Weaver Charitable Trust (P30 CA01667)
  • Astellas Pharma US

This publication has 37 references indexed in Scilit: